Genmab Total Non-Operating Income/Expense 2010-2025 | GNMSF
Genmab total non-operating income/expense for the twelve months ending March 31, 2025 was $0.280B, a 39.47% increase year-over-year.
- Genmab annual total non-operating income/expense for 2024 was $0.357B, a 677.73% increase from 2023.
- Genmab annual total non-operating income/expense for 2023 was $0.046B, a 52.21% decline from 2022.
- Genmab annual total non-operating income/expense for 2022 was $0.096B, a 37.47% decline from 2021.